The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies

10.7326/0003-4819-118-8-199304150-00009

Feeny D H, 1996, Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edn, 85

Patrick D L, 1993, Health status and health policy: quality of life in health care evaluation and resource allocation

Feeny D, 2000, Med Care, 9, II-151

von Neumann J, 1947, Theory of games and economic behavior. 2nd edn

Keeney R L, 1993, Decisions with multiple objectives: preferences and value tradeoffs. 2nd edn, 10.1017/CBO9781139174084

10.2165/00019053-199507060-00004

Furlong W, 1998, Multiplicative multi-attribute utility function for the Health Utilities Index Mark 3 (HUI3) system: a technical report

Torrance G W, 1995, PharmacoEconomics, 7, 503, 10.2165/00019053-199507060-00005

10.1097/00005650-199607000-00004

Ware J E, 1981, Am J Public Health, 71, 620, 10.2105/AJPH.71.6.620

10.1037/h0043158

Houle C, 2000, Quality of Life Newsletter, 24, 5

Neumann P J, 1999, Med Care, 37, 27, 10.1097/00005650-199901000-00005

Neumann P J, 1999, Neurology, 52, 1138, 10.1212/WNL.52.6.1138

10.1007/978-94-011-2952-7

10.1017/S0266462300008461

Furlong W, 1990, Guide to design and development of health-state utility instrumentation

10.1177/02729890122062622

Gold M R, 1996, Cost-effectiveness in health and medicine, 10.1093/oso/9780195108248.001.0001

Torrance G W, 1982, Operations Res, 30, 1042, 10.1287/opre.30.6.1043

Revicki D A, 1998, Qual Life Res, 7, 693, 10.1023/A:1008860113818

Revicki D A, 1998, Chest, 114, 998, 10.1378/chest.114.4.998

Le Galès C, Economie et Prévision

Froberg D G, 1989, J Clin Epidemiol, 42, 585, 10.1016/0895-4356(89)90155-8

Furlong W J, 1996, Variability of utility scores for health states among general population groups (MSc Thesis)

Richardson J, 1997, Med Decis Making, 17, 33, 10.1177/0272989X9701700104

Essink-Bot M L, 1993, Health Econ, 2, 237, 10.1002/hec.4730020307

10.2105/AJPH.75.12.1402

Balaban D J, 1986, Med Care, 24, 973, 10.1097/00005650-198611000-00001

Kaplan R M, 1994, Med Care, 32, 975, 10.1097/00005650-199410000-00001

10.2165/00019053-200017010-00002

Richardson J, 1999, Report to the Pharmaceutical Evaluation Section, Pharmaceutical Benefits Branch, Commonwealth Department of Health and Family Services, 25 March, 1999. Monash University, Australia

Barr R D, 2000, J Clin Oncol, 18, 3280, 10.1200/JCO.2000.18.18.3280

Grootendorst P, 2000, Med Care, 38, 290, 10.1097/00005650-200003000-00006

Szecket N, 1999, Int J Cancer, 119, 10.1002/(SICI)1097-0215(1999)83:12+<119::AID-IJC21>3.0.CO;2-9

Barr R D, 1999, Eur J Cancer, 35, 248, 10.1016/S0959-8049(98)00366-9

Glaser A W, 1999, Eur J Cancer, 35, 256, 10.1016/S0959-8049(98)00367-0

Furlong W J, 2001, The Health Utilities Index (HUP) system for assessing health-related quality of life in clinical trials

Costet N, 1998, Qual Life Res, 7, 245, 10.1023/A:1008830115246

Barr R D, 1997, Int J Oncol, 11, 333

Torrance G W, 1999, PhamacoEconomics, 15, 499, 10.2165/00019053-199916050-00007

Barr R D, 1993, Am J Pediatr Hematol Oncol, 15, 284

Whitton A C, 1997, Cancer, 80, 258, 10.1002/(SICI)1097-0142(19970715)80:2<258::AID-CNCR14>3.0.CO;2-T

Wang Q, 1999, Singapore Med J, 40, 389

Field M J, 1998, Summarizing population health: directions for the development and application of population metrics

Speechley K N, 1999, Int J Cancer, 95, 10.1002/(SICI)1097-0215(1999)83:12+<95::AID-IJC18>3.0.CO;2-H

Canadian Coordinating Office for Health Technology Assessment, 1994, Guidelines for economic evaluation of pharmaceuticals: Canada. 1st edn

10.1001/jama.281.21.1991

10.1016/S0895-4356(96)00314-9